FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

2.

Prior authorizations draining time, energy from many cancer patients

3.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

4.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

5.

X-ray and radar technology combined to reduce cancer screening risks


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot